½ÃÀ庸°í¼­
»óǰÄÚµå
1581303

¼¼°èÀÇ À¯¹æ °Ç°­ ½ÃÀå : Á¦Ç° À¯Çü, Åõ¿© °æ·Î, µ¿¹°Á¾, À¯Åë ä³Î, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Udder Health Market by Product Type (Diagnostics Products, Prevention Products, Treatment Products), Administration Route (Injectable, Oral, Topical), Animal Type, Distribution Channel, End-user - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 198 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

À¯¹æ °Ç°­ ½ÃÀåÀº 2023³â¿¡ 13¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 14¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 5.96%·Î ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 20¾ï 1,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯¹æ °Ç°­Àº ³«³óÀÇ Áß¿äÇÑ Ãø¸éÀ̸ç, »ýÀ¯ »ý»ê, ǰÁú, ¼öÀͼº¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. À¯¹æ¿° ¹× ±âŸ °ü·Ã Áúº´ÀÇ ¿¹¹æ, Áø´Ü ¹× Ä¡·á°¡ Æ÷ÇԵ˴ϴÙ. È¿°úÀûÀÎ À¯¹æ ÀǾàǰ °ü¸®´Â Á¥¼ÒÀÇ °Ç°­°ú ³óÀåÀÇ °æÁ¦Àû »ýÁ¸À» º¸ÀåÇÕ´Ï´Ù. ¼¼°èÀÇ ³«³ó ¼Òºñ·®ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Ç×»ýÁ¦¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ÁÙÀÌ°í µ¿¹° º¹Áö¸¦ È®º¸Çϸ鼭 À¯·®°ú À¯ÁúÀ» Çâ»ó½Ã۱â À§Çؼ­´Â °í±Þ À¯¹æ °Ç°­ °ü¸®°¡ ÇʼöÀûÀÔ´Ï´Ù. ±× ¿ëµµ´Â °³º° ³óÀå¿¡¼­ÀÇ ½ÇõºÎÅÍ ´ë±Ô¸ð »ê¾÷ °æ¿µ¿¡ À̸£±â±îÁö ¼ÒÀÇ ÄèÀû¼º Çâ»ó, Áø´Ü ±â¼ú Ȱ¿ë, ÂøÀ¯ ÇÁ·Î¼¼½º ÃÖÀûÈ­¿¡ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù. ÃÖÁ¾ ¿ëµµ¿¡´Â ÁÖ·Î ³«³ó°¡, ¼öÀÇ»ç ¼­ºñ½º, µ¿¹° ÀǾàǰ Á¦Á¶¾÷ü°¡ Æ÷ÇԵ˴ϴÙ. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â µ¿¹° º¹Áö¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡, ¼öÀÇÇÐ ±â¼úÀÇ Áøº¸, ³«³óÀå ÀÚµ¿È­¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ÃֽŠºñÁî´Ï½º ±âȸ´Â ¼¾¼­ ¹× AI¿Í °°Àº µðÁöÅÐ ±â¼úÀ» ½Ç½Ã°£ ¸ð´ÏÅ͸µ¿¡ ÅëÇÕÇÔÀ¸·Î½á ¹ß»ýÇÏ¸ç °Ç°­ ¹®Á¦°¡ ½É°¢ÇØÁö±â Àü¿¡ À̸¦ ¿¹ÃøÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ À¯¹æ¿°¿¡ ´ëÇÑ Ç×»ýÁ¦¸¦ »ç¿ëÇÏÁö ¾Ê´Â Çõ½ÅÀûÀÎ Ä¡·á¹ýÀ» °³¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª °íµµÀÇ Áø´Ü µµ±¸ÀÇ °íºñ¿ë, ÀüÅëÀûÀÎ ³ó°¡ÀÇ µµÀÔ¿¡ ´ëÇÑ ÀúÇ×, Áúº´ÀÇ º¹À⼺ µîÀÇ °úÁ¦°¡ ÀÖÀ¸¸ç, ÇѰ谡 ÀÖ½À´Ï´Ù. ½ÅÈï±¹ ½ÃÀå¿¡¼­´Â ±ÔÁ¦ Àå¾Ö¹°°ú °æÁ¦Àû Á¦¾àÀÌ ½ÃÀå °³Ã´À» ¸·À» ¼ö ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀÌ ÇÊ¿äÇÑ ºÐ¾ß·Î´Â ÃßÀû¼ºÀ» À§ÇÑ ºí·ÏüÀÎ, Á¥¼ÒÀÇ À¯ÀüÇÐÀû °³·®À» À§ÇÑ »ý¸í°øÇÐÀÇ ÀÀ¿ë, ¿¹¹æÁ¶Ä¡·Î¼­ÀÇ ¿µ¾çº¸Á¶½ÄǰÀÇ °­È­ µîÀÌ ÀÖ½À´Ï´Ù.ȯ°æ ģȭÀûÀ̰í Áö¼Ó °¡´ÉÇÑ ³ó¹ý¿¡ ´ëÇÑ Á¶»ç´Â ºñÁî´Ï½º ¼ºÀåÀÇ ±æÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÇÏÀÌÅ×Å© ±â¾÷°ú ³ó¾÷ Àü¹®°¡ÀÇ ÆÄÆ®³Ê½ÊÀº ³óÀå °íÀ¯ÀÇ ¿ä±¸¸¦ ÃæÁ·½ÃŰ´Â ÅëÇÕ ½Ã½ºÅÛÀ» ÃßÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î, À¯¹æ °Ç°­ ½ÃÀåÀº ¿ªµ¿ÀûÀ̸ç, ±âÁ¸ÀÇ ¼öÀÇÇп¡ ´ëÇÑ Á¢±Ù°ú ±ÕÇüÀ» ¸ÂÃ߸鼭 ±â¼ú Áß½ÉÀÇ ¼Ö·ç¼ÇÀ» ¼ö¿ëÇϰí Àֱ⠶§¹®¿¡ À¯¸ÁÇÑ ±Ëµµ¸¦ ±×¸³´Ï´Ù. ½ÃÀåÀÇ ÁøÈ­´Â ±³À°, Á¤Ã¥ Áö¿ø, ±âÁ¸ °úÁ¦¸¦ ±Øº¹Çϱâ À§ÇÑ À̾÷Á¾ Çù·Â¿¡ Å©°Ô ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 13¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 14¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 20¾ï 1,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 5.96%

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â À¯¹æ °Ç°­ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

À¯¹æ °Ç°­ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ëÀ̳ª ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼°è¿¡¼­ Áõ°¡ÇÏ´Â À¯¹æ¿°ÀÇ ¸¸¿¬
    • ¼¼°è À¯Á¦Ç° ¼ö¿ä Áõ°¡
    • À¯¹æ °Ç°­ °ü¸®¸¦ À§ÇÑ ³«³ó°¡ ±³À° ÇÁ·Î±×·¥ °³¹ß
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • À¯¹æ °Ç°­ °ü¸® ¼Ö·ç¼ÇÀÇ °íºñ¿ë
  • ½ÃÀå ±âȸ
    • À¯¹æ °Ç°­¿¡ ´ëÇÑ Çãºê³ª ÇÁ·Î¹ÙÀÌ¿Àƽ½º Ä¡·áÀÇ Å½±¸
    • ³«³ó¿¡¼­ÀÇ µðÁöÅÐ ±â¼ú°ú IoTÀÇ ÅëÇÕ
  • ½ÃÀåÀÇ °úÁ¦
    • µ¿¹°ÀÇ Ç×»ýÁ¦ ³»¼º¿¡ ´ëÇÑ ¿ì·Á Áõ°¡

Porter's Five Forces : À¯¹æ °Ç°­ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : À¯¹æ °Ç°­ ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº À¯¹æ ÀǾàǰ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® À¯¹æ ÀǾàǰ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

À¯¹æ °Ç°­ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º À¯¹æ ÀǾàǰ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â À¯¹æ °Ç°­ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ À¯¹æ °Ç°­ ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

À¯¹æ °Ç°­ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • Àü ¼¼°è¿¡¼­ À¯¹æ¿°ÀÇ ÀÌȯÀ²ÀÌ Áõ°¡
      • ¼¼°è À¯Á¦Ç° ¼ö¿ä Áõ°¡
      • À¯¹æ °Ç°­ °æ¿µÀ» À§ÇÑ ³ó°¡ ±³À° ÇÁ·Î±×·¥ÀÇ °³¹ß
    • ¾ïÁ¦¿äÀÎ
      • À¯¹æ °Ç°­ °ü¸® ¼Ö·ç¼ÇÀÇ °íºñ¿ë
    • ±âȸ
      • À¯¹æ °Ç°­ÀÇ Çãºê ¹× ÇÁ·Î¹ÙÀÌ¿Àƽ½º Ä¡·áÀÇ Å½»ö
      • ³«³ó¿¡¼­ÀÇ µðÁöÅÐ ±â¼ú°ú IoTÀÇ ÅëÇÕ
    • °úÁ¦
      • µ¿¹°ÀÇ Ç×»ýÁ¦ ³»¼º¿¡ ´ëÇÑ ¿ì·Á°¡ ³ô¾ÆÁø´Ù
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • Á¦Ç° À¯Çü : ¼Ò¸¦ º´¿øÃ¼·ÎºÎÅÍ ¸é¿ªÇϱâ À§ÇÑ ¹é½ÅÀÇ ÀÌ¿ë Áõ°¡
    • ÃÖÁ¾»ç¿ëÀÚ : ¼öÀǺ´¿øÀ̳ª Áø·á¼Ò Àüü¿¡¼­ À¯¹æ °Ç°­ °ü¸® ¼Ö·ç¼Ç ÀÌ¿ëÀÇ ÁøÈ­
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå À¯¹æ °Ç°­ ½ÃÀå : Á¦Ç° À¯Çüº°

  • Áø´Ü Á¦Ç°
    • ¿ìÀ¯ ¹è¾ç ŰƮ
    • PCR °Ë»ç ŰƮ
    • ü¼¼Æ÷ Ä«¿îÅÍ
  • ¿¹¹æÁ¦Ç°
    • ¼Òµ¶Á¦¿Í »ì±ÕÁ¦
    • ¿µ¾çº¸Á¶½Äǰ
    • ¹é½Å
  • Ä¡·áÁ¦Ç°
    • Ç׿°ÁõÁ¦
    • Ç×»ýÁ¦
    • À¯µÎ ½Ç¶õÆ®

Á¦7Àå À¯¹æ °Ç°­ ½ÃÀå : Åõ¿© °æ·Îº°

  • ÁÖ»ç
  • °æ±¸
  • ±¹¼Ò

Á¦8Àå À¯¹æ °Ç°­ ½ÃÀå : µ¿¹°À¯Çüº°

  • ¼Ò
  • ¿°¼Ò
  • ¾ç

Á¦9Àå À¯¹æ °Ç°­ ½ÃÀå : À¯Åë ä³Îº°

  • ¿ÀÇÁ¶óÀÎ
  • ¿Â¶óÀÎ

Á¦10Àå À¯¹æ °Ç°­ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ³óÀå°ú ³«³ó »ý»êÀÚ
  • µ¿¹°º´¿ø ¹× Ŭ¸®´Ð
  • ¼öÀÇ»ç Á¶»ç ±â°ü

Á¦11Àå ¾Æ¸Þ¸®Ä« À¯¹æ °Ç°­ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À¯¹æ °Ç°­ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦13Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ À¯¹æ °Ç°­ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • VetoquinolÀÇ ½º¸¶Æ® ±â¼úÀÌ À¯¹æ¿° °ü¸®¸¦ Çõ½ÅÇÏ¿© »ý»ê¼º°ú Áö¼Ó°¡´É¼ºÀ» Çâ»ó
    • DeLaval, OceanBlu ½Ã¸®Áî·Î À¯¹æ °Ç°­À» Çõ½Å, »õ·Î¿î ±Û¸®ÄÝ»ê À¯µÎ ¼Òµ¶Á¦°¡ ³«³ó »ý»ê¼º°ú Áö¼Ó°¡´É¼ºÀ» Çâ»ó
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • ABS Global, Inc.
  • Afimilk Ltd.
  • AgriLabs, Ltd.
  • Ariake Japan Co., Ltd.
  • Boehringer Ingelheim Vetmedica, Inc.
  • BouMatic LLC
  • Ceva Sante Animale
  • Dairy Master Inc.
  • DeLaval International AB
  • Elanco Animal Health Incorporated
  • GEA Group AG
  • IDEXX Laboratories, Inc.
  • ImmuCell Corporation
  • Merck & Co., Inc.
  • Milk Specialties Global, Inc.
  • Neogen Corporation
  • Norbrook Laboratories Limited
  • Performance Health, LLC
  • SCR Dairy, Inc.
  • Udder Tech, Inc.
  • Vetoquinol SA
  • Virbac Corporation
  • Westfalia Dairy Systems, Inc.
  • Zoetis Inc.
BJH 24.11.07

The Udder Health Market was valued at USD 1.34 billion in 2023, expected to reach USD 1.42 billion in 2024, and is projected to grow at a CAGR of 5.96%, to USD 2.01 billion by 2030.

Udder health is a critical aspect of dairy farming, influencing milk production, quality, and profitability. It encompasses the prevention, diagnosis, and treatment of mastitis and other related conditions. Effective udder health management ensures the well-being of dairy cattle and the economic viability of farms. With global dairy consumption rising, the necessity for advanced udder health management practices is paramount to enhance milk yield and quality while reducing antibiotic reliance and ensuring animal welfare. Applications extend from individual farm practices to large-scale industrial operations, focusing on improving cow comfort, leveraging diagnostics technology, and optimizing milking processes. The end-use scope primarily involves dairy producers, veterinary services, and animal health product manufacturers. Key growth factors include increasing awareness of animal welfare, advancements in veterinary technology, and growing investment in dairy farm automation. Latest opportunities arise from integrating digital technologies like sensors and AI for real-time monitoring, which can anticipate health issues before they escalate. There's also potential in developing innovative, non-antibiotic treatments for mastitis. However, challenges such as high costs of advanced diagnostic tools, resistance to adoption among traditional farmers, and the complexity of diseases present limitations. Market growth can be stymied by regulatory hurdles and economic constraints in developing regions. Areas ripe for innovation include blockchain for traceability, applying biotechnology to improve dairy cattle genetics, and enhancing nutraceuticals as preventive measures. Research into eco-friendly, sustainable farming practices provides an avenue for business growth. Furthermore, partnerships between tech companies and agriculture specialists can drive integrated systems that cater to farm-specific needs. Overall, the udder health market is dynamic, with a promising trajectory as it embraces technology-led solutions while balancing traditional approaches to veterinary care. The market's evolution is heavily dependent on education, policy support, and cross-industry collaboration to overcome existing challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 1.34 billion
Estimated Year [2024] USD 1.42 billion
Forecast Year [2030] USD 2.01 billion
CAGR (%) 5.96%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Udder Health Market

The Udder Health Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of mastitis across the globe
    • Growing demand for dairy products globally
    • Development of farmer education programs for udder health management
  • Market Restraints
    • High cost of udder health management solutions
  • Market Opportunities
    • Exploration of herbal and probiotic treatments for udder health
    • Integration of digital technologies and IoT in dairy farming
  • Market Challenges
    • Growing concern over antibiotic resistance among animals

Porter's Five Forces: A Strategic Tool for Navigating the Udder Health Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Udder Health Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Udder Health Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Udder Health Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Udder Health Market

A detailed market share analysis in the Udder Health Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Udder Health Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Udder Health Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Udder Health Market

A strategic analysis of the Udder Health Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Udder Health Market, highlighting leading vendors and their innovative profiles. These include ABS Global, Inc., Afimilk Ltd., AgriLabs, Ltd., Ariake Japan Co., Ltd., Boehringer Ingelheim Vetmedica, Inc., BouMatic LLC, Ceva Sante Animale, Dairy Master Inc., DeLaval International AB, Elanco Animal Health Incorporated, GEA Group AG, IDEXX Laboratories, Inc., ImmuCell Corporation, Merck & Co., Inc., Milk Specialties Global, Inc., Neogen Corporation, Norbrook Laboratories Limited, Performance Health, LLC, SCR Dairy, Inc., Udder Tech, Inc., Vetoquinol SA, Virbac Corporation, Westfalia Dairy Systems, Inc., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Udder Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Diagnostics Products, Prevention Products, and Treatment Products. The Diagnostics Products is further studied across Milk Culturing Kits, PCR Testing Kits, and Somatic Cell Counters. The Prevention Products is further studied across Disinfectants & Sanitizers, Nutrition Supplements, and Vaccines. The Treatment Products is further studied across Anti-inflammatory Drugs, Antibiotics, and Teat Sealants.
  • Based on Administration Route, market is studied across Injectable, Oral, and Topical.
  • Based on Animal Type, market is studied across Cattle, Goats, and Sheep.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on End-user, market is studied across Farms & Dairy Producers, Veterinary Hospitals & Clinics, and Veterinary Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of mastitis across the globe
      • 5.1.1.2. Growing demand for dairy products globally
      • 5.1.1.3. Development of farmer education programs for udder health management
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of udder health management solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Exploration of herbal and probiotic treatments for udder health
      • 5.1.3.2. Integration of digital technologies and IoT in dairy farming
    • 5.1.4. Challenges
      • 5.1.4.1. Growing concern over antibiotic resistance among animals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Increasing utilization of the vaccines to immunize cows against pathogens
    • 5.2.2. End-user: Evolving utilization of the udder health management solutions across veterinary hospitals and clinics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Udder Health Market, by Product Type

  • 6.1. Introduction
  • 6.2. Diagnostics Products
    • 6.2.1. Milk Culturing Kits
    • 6.2.2. PCR Testing Kits
    • 6.2.3. Somatic Cell Counters
  • 6.3. Prevention Products
    • 6.3.1. Disinfectants & Sanitizers
    • 6.3.2. Nutrition Supplements
    • 6.3.3. Vaccines
  • 6.4. Treatment Products
    • 6.4.1. Anti-inflammatory Drugs
    • 6.4.2. Antibiotics
    • 6.4.3. Teat Sealants

7. Udder Health Market, by Administration Route

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Oral
  • 7.4. Topical

8. Udder Health Market, by Animal Type

  • 8.1. Introduction
  • 8.2. Cattle
  • 8.3. Goats
  • 8.4. Sheep

9. Udder Health Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Udder Health Market, by End-user

  • 10.1. Introduction
  • 10.2. Farms & Dairy Producers
  • 10.3. Veterinary Hospitals & Clinics
  • 10.4. Veterinary Research Institutes

11. Americas Udder Health Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Udder Health Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Udder Health Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Vetoquinol's Smart Tech Revolutionizes Mastitis Management for Enhanced Productivity and Sustainability
    • 14.3.2. DeLaval Innovates Udder Health with OceanBlu Range, New Glycolic Acid Teat Disinfectants Enhance Dairy Productivity and Sustainability
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ABS Global, Inc.
  • 2. Afimilk Ltd.
  • 3. AgriLabs, Ltd.
  • 4. Ariake Japan Co., Ltd.
  • 5. Boehringer Ingelheim Vetmedica, Inc.
  • 6. BouMatic LLC
  • 7. Ceva Sante Animale
  • 8. Dairy Master Inc.
  • 9. DeLaval International AB
  • 10. Elanco Animal Health Incorporated
  • 11. GEA Group AG
  • 12. IDEXX Laboratories, Inc.
  • 13. ImmuCell Corporation
  • 14. Merck & Co., Inc.
  • 15. Milk Specialties Global, Inc.
  • 16. Neogen Corporation
  • 17. Norbrook Laboratories Limited
  • 18. Performance Health, LLC
  • 19. SCR Dairy, Inc.
  • 20. Udder Tech, Inc.
  • 21. Vetoquinol SA
  • 22. Virbac Corporation
  • 23. Westfalia Dairy Systems, Inc.
  • 24. Zoetis Inc.
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦